This analyst loves Hammond Power

Paradigm Capital analyst Razi Hasan initiated coverage of Hammond Power Solutions (Hammond Power Solutions Stock Quote, Chart, N...

Rod Weatherbie 15 hours ago
HPS.A:CA
  • This weed stock is undervalued, analyst says

    Nick Waddell 15 hours ago
    TRUL:CNX
  • This analyst just upped his price target on Knight Therapeutics

    Rod Weatherbie 3 days ago
    GUD:CA
  • Kinaxis is rolling, this analyst says

    Nick Waddell 3 days ago
    KXS:CA
  • This analyst just raised his price target on Curaleaf

    Nick Waddell 3 days ago
    CURA:CA
  • Buy this pot stock for a double, analyst says

    Nick Waddell 4 days ago
    HITI
  • Cryoport stock is a buy, this analyst says

    Rod Weatherbie 4 days ago
    CYRX
  • Eupraxia wins new (US) $15.50 target at Leede Financial

    Nick Waddell 4 days ago
    EPRX
  • Thinkific Labs: Buy, Sell or Hold?

    Rod Weatherbie 4 days ago
    THNC:CA

This analyst just upped his price target on Knight Therapeutics

Research Capital analyst Andre Uddin raised his target on Knight Therapeutics (Knight Therapeutics Stock Quote, Chart, News, Analysts, Financials TSX:GUD) to C$9.80 from C$8.55, maintaining a “Buy” rating in a May 7 report after what he called another ...

GUD:CA
3 days ago
  • Telus upgraded to “Buy” at TD

    Nick Waddell April 29, 2026
    T:CA
  • Will AI kill Shopify?

    Nick Waddell April 29, 2026
    SHOP:CA
    KXS:CA

More News

  • This analyst loves Hammond Power

    Rod Weatherbie 15 hours ago
    HPS.A:CA
  • This weed stock is undervalued, analyst says

    Nick Waddell 15 hours ago
    TRUL:CNX
  • This analyst just upped his price target on Knight Therapeutics

    Rod Weatherbie 3 days ago
    GUD:CA
  • Kinaxis is rolling, this analyst says

    Nick Waddell 3 days ago
    KXS:CA
  • This analyst just raised his price target on Curaleaf

    Nick Waddell 3 days ago
    CURA:CA
  • Buy this pot stock for a double, analyst says

    Nick Waddell 4 days ago
    HITI
  • Cryoport stock is a buy, this analyst says

    Rod Weatherbie 4 days ago
    CYRX
  • Eupraxia wins new (US) $15.50 target at Leede Financial

    Nick Waddell 4 days ago
    EPRX
displaying rededs